In an email to Reuters Health, Dr. Granger added that “while bleeding can occur with anticoagulation for AF, serious bleeding (like intracranial bleeding) is far less common than with warfarin, and the benefits of preventing stroke far outweigh the risk of bleeding for nearly all patients. For patients on anticoagulation, measures to reduce bleeding risk (like avoiding aspirin) are important. When bleeding does occur, reversal agents are available, although how to best use them is uncertain.”
The study had no specific funding. One of Dr. Gomez-Outes’ coauthors reports financial ties to drugmakers.
Pages: 1 2 | Single Page
No Responses to “DOAC-prompted Bleeding Fatal in Some Patients, Despite Successful Reversal in Many”